Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|November 30, 2007
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraJames B Bussel, Gregory Cheng, Mansoor N Saleh, et al.
Journal of Thrombosis and Haemostasis : JTH|February 14, 2025
Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on von Willebrand FactorWynn Peterson, Rachel Martin, Donald Arnold, et al.
British Journal of Haematology|March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) networkGuillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
American Journal of Hematology|October 27, 2020
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
American Journal of Hematology|November 10, 2020
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatmentNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
British Journal of Haematology|November 24, 2016
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonistsJecko Thachil, Catherine Bagot, Charlotte Bradbury, et al.
British Journal of Haematology|March 2, 2024
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT studyNichola Cooper, Marie Scully, Charles Percy, et al.
Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.
Haematologica|June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registriesGuillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|November 30, 2007
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraJames B Bussel, Gregory Cheng, Mansoor N Saleh, et al.
Journal of Thrombosis and Haemostasis : JTH|February 14, 2025
Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on von Willebrand FactorWynn Peterson, Rachel Martin, Donald Arnold, et al.
British Journal of Haematology|March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) networkGuillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
American Journal of Hematology|October 27, 2020
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
American Journal of Hematology|November 10, 2020
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatmentNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
British Journal of Haematology|November 24, 2016
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonistsJecko Thachil, Catherine Bagot, Charlotte Bradbury, et al.
British Journal of Haematology|March 2, 2024
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT studyNichola Cooper, Marie Scully, Charles Percy, et al.
Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.
Haematologica|June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registriesGuillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
Pageof 9